Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Mary Jeanne Kallman | Researchclopedia

Back to researchers

Mary Jeanne Kallman

99

Works

1,812

Citations

20

h-index

29

i10-index

Research Topics

Neurotransmitter Receptor Influence on Behavior Neuroscience and Neuropharmacology Research Animal testing and alternatives

Affiliations

Eli Lilly (United States)1995–2009

Virginia Commonwealth University1982–1982

Karolinska Institutet1989–1989

University of Mississippi1987–2000

LEK Consulting (United States)2015–2015

Top Works

Design, Synthesis, and Pharmacological Characterization of (+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY354740): A Potent, Selective, and Orally Active Group 2 Metabotropic Glutamate Receptor Agonist Possessing Anticonvulsant and Anxiolytic Properties

James A. Monn,Matthew J. Valli,et al.

1997392 citations

Receptor Mechanisms and Signaling

Stress Responses and Cortisol

Anxiolytic and Side-Effect Profile of LY354740: A Potent, Highly Selective, Orally Active Agonist for Group II Metabotropic Glutamate Receptors

David R. Helton,J P Tizzano,et al.

1998282 citations

Benchmarking Safety Pharmacology regulatory packages and best practice

Silvana Lindgren,Alan Bass,et al.

2008107 citations

LY354740: a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats

David R. Helton,Joseph P. Tizzano,et al.

1997103 citations

2-Substituted (2<i>SR</i>)-2-Amino-2-((1<i>SR</i>,2<i>SR</i>)-2-carboxycycloprop-1-yl)glycines as Potent and Selective Antagonists of Group II Metabotropic Glutamate Receptors. 2. Effects of Aromatic Substitution, Pharmacological Characterization, and Bioavailability

Paul L. Ornstein,Thomas J. Bleisch,et al.

1998100 citations

A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder

Himanshu P. Upadhyaya,D. Desaiah,et al.

201367 citations

The Novel 5-Hydroxytryptamine1A Antagonist LY426965: Effects on Nicotine Withdrawal and Interactions with Fluoxetine

Kurt Rasmussen,David O. Calligaro,et al.

200058 citations

LY303870, a Centrally Active Neurokinin-1 Antagonist with a Long Duration of Action

Satish Iyengar,Philip A. Hipskind,et al.

199758 citations

Translational Biomarkers of Neurotoxicity: A Health and Environmental Sciences Institute Perspective on the Way Forward

Ruth Roberts,Michael Aschner,et al.

201556 citations